Session 4 – Cross Border Investments
Date: 25 July (Thursday) 14:00 – 17:40 Venue: 3F, Bldg. A, CTBC Financial Park, Ballroom A
Rong jin Lin
Center Laboratories Inc.
Biotechnology entrepreneurship and investment
Enterprise positioning and restructuring
Business strategy & organizational model
International resource integration
Chairman and General Manager, TTY Biopharm Company Limited
Chairman, PharmaEngine, Inc.
Honorary Doctorate, College of Medicine, Taipei Medical University
B.S., College of Pharmacy, Taipei Medical University
Session Speech Title & Synopsis: The Key Drivers and Success Story for M&A in Biotechnology Sectoor
The growth of a company included the organic and strategic growth; and the strategic growth usually can be achieved by diverse approaches like partnerships, alliances, mergers, acquisitions, joint ventures, buy-outs and spin-outs. In pharmseutical industry, new drug development is a challenging and lengthy process, most of the companies have difficulties to survive from this costly and time-consuming journey. How to flexibly use the above approaches to overcome the hurdles will be the key to determining the sustain of a company. Mr. Rongjin Lin will be sharing his over thirty years’ experience in several case studies in the following session.